In vitro Evaluation of Antiviral Efficacy of a Standardized Hydroalcoholic Extract of Poplar Type Propolis Against SARS-CoV-2

Except for specific vaccines and monoclonal antibodies, effective prophylactic or post-exposure therapeutic treatments are currently limited for COVID-19. Propolis, a honeybee’s product, has been suggested as a potential candidate for treatment of COVID-19 for its immunomodulatory properties and for...

Descripción completa

Detalles Bibliográficos
Autores principales: Sberna, Giuseppe, Biagi, Marco, Marafini, Giovanni, Nardacci, Roberta, Biava, Mirella, Colavita, Francesca, Piselli, Pierluca, Miraldi, Elisabetta, D’Offizi, Gianpiero, Capobianchi, Maria Rosaria, Amendola, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958028/
https://www.ncbi.nlm.nih.gov/pubmed/35350622
http://dx.doi.org/10.3389/fmicb.2022.799546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958028/
https://www.ncbi.nlm.nih.gov/pubmed/35350622
http://dx.doi.org/10.3389/fmicb.2022.799546

Ejemplares similares